ABBV

NYSE · Biotechnology

Abbvie Inc

S&P 500 Mega-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks

$246.04

+2.17 (+0.89%)

As of Aug 8, 9:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 31 79%

Hold 8 21%

Sell 0 0%

Price Target

Analyst Price Target +4.7% upside

Low Target $173.19

Average Target $257.58

High Target $337.66

Current Price $246.04

Current
$246.04

Target
$257.58

$173.19 $257.58 avg $337.66

Scenario Analysis

Bear Case

$173.19

-29.6%

Low target

Base Case

$257.58

+4.7%

Avg target

Bull Case

$337.66

+37.2%

High target

Risk/Reward

1.3x

Balanced

Price in Context

52-Week High

$267.47

-8.0% from high

52-Week Low

$190.75

+29.0% from low

50-Day SMA

$223.82

+9.9% vs SMA

200-Day SMA

$211.12

+16.5% vs SMA

RSI (14)

54.5

Neutral

Target vs 52W High

$257.58

-3.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%